Markus J. Seibel

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes

Danijela Gnjidic, Sarah N. Hilmer, Fiona Blyth et al. · Journal of Clinical Epidemiology · 2012 · 1.1K citations

Drug Safety, Polypharmacy Cutoff, Aging +12

Biochemical markers of bone turnover: part I: biochemistry and variability.

Markus J. Seibel · PubMed · 2005 · 576 citations

Molecular Markers, Pathology, Osteoporosis +20

Loss of Muscle Strength, Mass (Sarcopenia), and Quality (Specific Force) and Its Relationship with Functional Limitation and Physical Disability: The Concord Health and Ageing in Men Project

Noran Naqiah Hairi, Robert G. Cumming, Vasi Naganathan et al. · Journal of the American Geriatrics Society · 2010 · 496 citations

Bone Mass, Vitamin D Deficiency, and Hyperparathyroidism in Congestive Heart Failure

Elizabeth Shane, Donna Mancini, Keith D. Aaronson et al. · The American Journal of Medicine · 1997 · 357 citations · Full text

Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption

Simon P. Robins, Henning W. Woitge, R. Hesley et al. · Journal of Bone and Mineral Research · 1994 · 323 citations

Orthopaedic Surgery, Osteoporosis, Musculoskeletal Research +19